HRV scaling exponent identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone.
Roberto SassiSergio CeruttiKaterina HnatkovaMarek MalikMaria G. SignoriniPublished in: IEEE Trans. Biomed. Eng. (2006)
Keyphrases
- medical treatment
- clinical studies
- medical care
- cancer patients
- ischemic stroke
- medical doctors
- therapy planning
- clinical information
- acute coronary syndrome
- real patient data
- disease progression
- acute myeloid
- clinical diagnosis
- liver disease
- chronic disease
- clinically relevant
- acute myocardial infarction
- cancer treatment
- deep brain stimulation
- treatment plan
- clinical data
- radiation therapy
- patient outcomes
- power law
- medical staff
- health care
- medical data
- patient specific
- heart rate variability
- diagnostic tool
- breast cancer patients
- breast cancer
- clinical trials
- electronic medical record
- medical images
- healthy controls
- cardiovascular disease
- prostate cancer
- high risk
- information systems
- drug resistance
- neurological disorders
- decision support system